412 results on '"Yamaguchi, Miki"'
Search Results
2. Real-world progression-free survival and overall survival of palbociclib plus endocrine therapy (ET) in Japanese patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer in the first-line or second-line setting: an observational study
3. Correction: Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM)
4. Impact of daily breakfast intake on the outcomes of assisted reproductive technology procedures
5. Histopathology of non-mass-like breast lesions on ultrasound
6. Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM)
7. Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial
8. Development of an intraoperative breast cancer margin assessment method using quantitative fluorescence measurements
9. Relationship between salt intake and sleep disordered breathing in dialysis patients
10. ER staining levels affect HER2 staining and heterogeneity
11. A Newly Developed Anti-L1CAM Monoclonal Antibody Targets Small Cell Lung Carcinoma Cells.
12. Small Cell Lung Carcinoma Cells Depend on KIF11 for Survival.
13. The efficacy and safety of pertuzumab plus trastuzumab and docetaxel as a first-line therapy in Japanese patients with inoperable or recurrent HER2-positive breast cancer: the COMACHI study
14. Androgen receptor expression is useful to predict the therapeutic effect in HER2-positive breast carcinoma
15. Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study
16. Fulvestrant with or without anti‐HER2 therapy in patients in a postmenopausal hormonal state and with ER‐positive HER2‐positive advanced or metastatic breast cancer: A subgroup analysis of data from the Safari study (JBCRG‐C06)
17. Dual inhibition of KIF11 and BCL2L1 induces apoptosis in lung adenocarcinoma cells
18. Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial–mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis
19. Junctional adhesion molecule 3 is a potential therapeutic target for small cell lung carcinoma
20. Supplementary Data from Datopotamab Deruxtecan, a Novel TROP2-directed Antibody–drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells
21. Abstract PD7-01: Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: A multicenter retrospective study (ROSET-BM study)
22. Abstract P2-03-15: Retrospective study using database for the effectiveness of medroxyprogesterone acetate in patients with ER-positive/HER2-negative postmenopausal advanced breast cancer: An additional analysis of the JBCRG-C06 Safari study
23. Multi-tracer sentinel node biopsy for patients with breast cancer after neoadjuvant chemotherapy
24. A Case of Breast Cancer with Rapid Tumor Progression at Puncture Site after Core Needle Biopsy
25. Optimization of Experimental Parameters for the Performance of Solid-state Dye-sensitized Solar Cells
26. Retrospective study on the effectiveness of medroxyprogesterone acetate in the treatment of ER-positive/HER2-negative post-menopausal advanced breast cancer: an additional analysis of the JBCRG-C06 Safari study
27. Adjuvant trastuzumab without chemotherapy for treating early HER2-positive breast cancer in older patients: A propensity score-adjusted analysis of a prospective cohort study
28. Dual inhibition of BCL2L1 and MCL1 is highly effective against RET fusion-positive or MET exon 14 skipping mutation-positive lung adenocarcinoma cells
29. Tumor-infiltrating lymphocytes are important pathologic predictors for neoadjuvant chemotherapy in patients with breast cancer
30. Anthrax toxin receptor 2 is a potential therapeutic target for non-small cell lung carcinoma with MET exon 14 skipping mutations
31. Myxomatous fibroadenoma of the breast: correlation with clinicopathologic and radiologic features
32. Factors associated with overall survival after recurrence in patients with ER-positive/HER2-negative postmenopausal breast cancer: an ad hoc analysis of the JBCRG-C06 Safari study
33. Development of An Intraoperative Breast Cancer Margin Assessment Method Using Quantitative Fluorescence Measurements
34. O2-17-3 - The frequency of febrile neutropenia in Japanese patients with breast cancer received perioperative chemotherapy
35. Retrospective study on the effectiveness of medroxyprogesterone acetate in the treatment of ER-positive/HER2-negative post-menopausal advanced breast cancer: an additional analysis of the JBCRG-C06 Safari study.
36. Management of breast papillary lesions diagnosed in ultrasound-guided vacuum-assisted and core needle biopsies
37. MCL1 inhibition enhances the efficacy of docetaxel against airway-derived squamous cell carcinoma cells
38. Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214
39. Datopotamab Deruxtecan, a Novel TROP2-directed Antibody–drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells
40. Adjuvant Trastuzumab Without Chemotherapy For Treating Early HER2-Positive Breast Cancer In Older Patients: A Cohort Study Accompanying With The RESPECT Trial
41. Immunohistochemical study of metaplastic carcinoma and central acellular carcinoma of the breast: central acellular carcinoma is related to metaplastic carcinoma
42. Ultrasonographic tissue quantification of the breast using acoustic radiation force impulse technology: phantom study and clinical application
43. “High-grade” central acellular carcinoma and matrix-producing carcinoma of the breast: correlation between ultrasonographic findings and pathological features
44. Ultrasonographic elastography of the breast using acoustic radiation force impulse technology: preliminary study
45. Detectability of breast lesions under the nipple using an automated breast volume scanner: comparison with handheld ultrasonography
46. Optimal scanning technique to cover the whole breast using an automated breast volume scanner
47. Pleomorphic carcinoma of the breast in a 17-year-old woman
48. Broad fibrovascular cores may not be an exclusively benign feature in papillary lesions of the breast: a cautionary note
49. Neuroendocrine small cell carcinoma of the breast: report of a case
50. Baseline neutrophil-to-lymphocyte ratio and absolute lymphocyte count in patients with HER2-negative breast cancer treated with eribulin may predict overall survival.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.